SDBJ: Onchilles Pharma Shares Promising Preclinical Data; New Mechanism Discovered Could Treat Wide Range of Cancers

Jeff Clemetson of the San Diego Business Journal talked with Onchilles after the Company’s presenation at AACR 2024 of new preclinical data for N17350 and N17465 demonstrating the potential for potent and tumor-selective treatment (read the release here).

To read the SDBJ article, click here.